Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

MEIP

MEI Pharma (MEIP)

MEI Pharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MEIP
DateTimeSourceHeadlineSymbolCompany
05/21/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MEIPMEI Pharma Inc
05/21/20241:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
05/20/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MEIPMEI Pharma Inc
05/09/20244:02PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
05/09/20244:02PMBusiness WireMEI Pharma Reports Third Quarter Fiscal Year 2024 Results and Operational HighlightsNASDAQ:MEIPMEI Pharma Inc
05/09/20244:00PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MEIPMEI Pharma Inc
04/11/20248:02AMBusiness WireMEI Pharma Board of Directors Aligns on Strategy to Advance Voruciclib and ME-344NASDAQ:MEIPMEI Pharma Inc
04/11/20248:00AMBusiness WireMEI Pharma Reports Initial Data from Clinical Study Evaluating ME-344 in Combination with Bevacizumab (AvastinĀ®) in Relapsed Metastatic Colorectal Cancer PatientsNASDAQ:MEIPMEI Pharma Inc
04/10/20248:00AMBusiness WireMEI Pharma to Present at the Stifel 2024 Virtual Targeted Oncology ForumNASDAQ:MEIPMEI Pharma Inc
03/26/20248:00AMBusiness WireMEI Pharma Reports Update from Clinical Study Evaluating Oral CDK9 Inhibitor Voruciclib in Combination with Venetoclax in Patients with Relapsed and Refractory Acute Myeloid LeukemiaNASDAQ:MEIPMEI Pharma Inc
02/29/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MEIPMEI Pharma Inc
02/21/20244:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
02/20/20245:33PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:MEIPMEI Pharma Inc
02/13/20245:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
02/13/20245:05PMBusiness WireMEI Pharma Reports Second Quarter Fiscal Year 2024 Results and Operational HighlightsNASDAQ:MEIPMEI Pharma Inc
01/17/20244:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
01/16/20245:00PMBusiness WireMEI Pharma to Present Design of Ongoing Clinical Study Evaluating ME-344 at ASCO GI Cancers Symposium 2024NASDAQ:MEIPMEI Pharma Inc
01/12/20244:00PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:MEIPMEI Pharma Inc
01/12/20244:00PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:MEIPMEI Pharma Inc
12/26/20235:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
12/22/20234:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
12/20/20239:26PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MEIPMEI Pharma Inc
12/20/20239:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MEIPMEI Pharma Inc
12/18/20234:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
12/11/20234:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
12/11/202312:00PMBusiness WireMEI Pharma Reports Clinical Data on Oral CDK9 Inhibitor Voruciclib at ASH2023NASDAQ:MEIPMEI Pharma Inc
11/14/20238:59PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MEIPMEI Pharma Inc
11/09/20234:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
11/09/20234:05PMBusiness WireMEI Pharma Reports First Quarter Fiscal Year 2024 Results and Operational HighlightsNASDAQ:MEIPMEI Pharma Inc
11/09/20234:00PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MEIPMEI Pharma Inc
 Showing the most relevant articles for your search:NASDAQ:MEIP

Your Recent History

Delayed Upgrade Clock